Summary of Purpose
This will be a randomized double blind placebo-controlled pilot study using a repeated measures design in which participants with acute ischemic stroke and intracranial atherosclerotic disease are randomized to either drug or placebo.Read More →
The following dates are available for this trial. Trial information last updated on 24 April 2018.
|1 Jun 2018||13 Apr 2018||28 Sep 2020||28 Sep 2021||1 Apr 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Adam de Havenon, MD
- Scott McNally, MD, PhD